Head-to-head · WeighScore
Fitish vs Henry Meds
By GLP-1 ScorecardUpdated
Score comparison
Henry Meds has the higher recorded score — 77.3/100 to 60.9/100.
Henry Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Henry's low monthly equivalents come with a full year paid upfront, so it is a poor fit for someone shopping for a short trial.
Before you choose
Fitish does not publish a semaglutide price, so its Fitish review sets out what it does disclose, while the Henry Meds review explains the conditions attached to Henry Meds's figure. The semaglutide cost page compares published rates across the field. Ask Fitish for a written total before treating either one as the cheaper choice.
If neither one fits, Fitish vs MadeMed and Fitstry vs Henry Meds compare each of them with another graded program, and the list of alternatives to Fitish ranks the programs closest to Fitish on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the GoodLife Health review covers one graded close to these two, at 69.8/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Fitish | Henry Meds |
|---|---|---|
| WeighScore | 60.9/100 | 77.3/100 |
| Grade | C | C+ |
| Site position | #335 | #47 |
| Semaglutide | No current public GLP-1 price verified | $197/mo (injectable; 12-month plan paid upfront in full, $2,364) |
| Tirzepatide | No current public GLP-1 price verified | Oral compounded plans; confirm selected price and supply |
| Coverage | Confirm treatment availability in your state | Multi-state |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
FDAWarning letter issued to FITISH in June 2026. See the FDA warning-letter database.
Strengths
- Public site describes clinician-guided care and oral GLP-1 options
What to consider
- Selected first and refill charges need confirmation
- Prescription-specific refund and cancellation terms were not verified
Site position #47 · C+
Strengths
- Published plan prices identify their upfront-payment requirement
- Medication, provider access, applicable supplies and shipping included if prescribed
- Compounded injectable semaglutide and oral options listed
What to consider
- The $197 semaglutide headline requires $2,364 upfront, not monthly payments
- Oral program headings and supply descriptions conflict; obtain the selected written quote
- Multi-month balances may remain payable after cancellation; medical-discontinuation refunds require documentation and approval, and dispensed medication is excluded
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.